Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy
Clinical trial NCT06558084 · COMPLETED
Trial details
- NCT number
- NCT06558084
- Sponsor
- Ain Shams University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-06
- Primary completion
- 2024-07-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.